- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 487521, 7 pages
TRAF1 Gene Polymorphism Correlates with the Titre of Gp210 Antibody in Patients with Primary Biliary Cirrhosis
1Medical Biology Laboratory, Department of Laboratory Diagnostics and Molecular Medicine, Pomeranian Medical University, 70-111 Szczecin, Poland
2INOVA Diagnostics, San Diego, CA 92131-1638, USA
3Liver Unit, Pomeranian Medical University, 70-111 Szczecin, Poland
4Institute of Liver Studies, School of Medicine, King's College London, London SE5 9RS, UK
Received 28 August 2012; Accepted 22 September 2012
Academic Editor: Pietro Invernizzi
Copyright © 2012 Agnieszka Kempinska-Podhorodecka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citations to this Article [2 citations]
The following is the list of published articles that have cited the current article.
- Yannick Chantran, Eric Ballot, and Catherine Johanet, “Autoantibodies in primary biliary cirrhosis: Antinuclear envelope autoantibodies,” Clinics and Research in Hepatology and Gastroenterology, 2013.
- Joanna Raszeja-Wyszomirska, Ewa Wunsch, Agnieszka Kempinska-Podhorodecka, Daniel S. Smyk, Dimitrios P. Bogdanos, Malgorzata Milkiewicz, and Piotr Milkiewicz, “TRAF1-C5 Affects Quality of Life in Patients with Primary Biliary Cirrhosis,” Clinical and Developmental Immunology, vol. 2013, pp. 1–7, 2013.